The many faces of tumor necrosis factor in stroke.
Hallenbeck
John M
JM
Stroke Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. hallenbj@ninds.nih.gov
D000818:Animals; D015703:Antigens, CD / Q000502:physiology; D001161:Arteriosclerosis / Q000209:etiology; D002545:Brain Ischemia / Q000209:etiology; D004730:Endothelium, Vascular / Q000378:metabolism; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology; D047888:Receptors, Tumor Necrosis Factor, Type I; D020521:Stroke / Q000209:etiology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000502:physiology*
D015703:Antigens, CD; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D014409:Tumor Necrosis Factor-alpha